Dr. Chaudhary obtained his medical degree in 1988 from Delhi University, Maulana Azad Medical College. He then received a PhD from the University of Illinois at Chicago in 1993 under the supervision of Dr. Igor Roninson, where he did pioneering research in the isolation and characterization of bone marrow stem cells and mechanism of multi-drug resistance to cancer chemotherapy. He was the first to describe the expression of P-glycoprotein, the product of human multidrug resistance gene (MDR1), in hematopoietic stem cells and selected subsets of lymphocytes. Dr. Chaudhary is Professor of Medicine and the Bloom Chair in Lymphoma Research. He
Dr. Chaudhary obtained his medical degree in 1988 from Delhi University, Maulana Azad Medical College. He then received a PhD from the University of Illinois at Chicago in 1993 under the supervision of Dr. Igor Roninson, where he did pioneering research in the isolation and characterization of bone marrow stem cells and mechanism of multi-drug resistance to cancer chemotherapy. He was the first to describe the expression of P-glycoprotein, the product of human multidrug resistance gene (MDR1), in hematopoietic stem cells and selected subsets of lymphocytes. Dr. Chaudhary is Professor of Medicine and the Bloom Chair in Lymphoma Research. He is also Division Chief of the Jane Ann Nohl Division of Hematology and Blood Diseases and director of USC Blood and Marrow Transplant Program. Dr. Chaudhary has authored or co-authored publications in such outstanding journals as Cell, Immunity, JNCI, Blood and PNAS, and holds six US patents in the areas of hematopoietic stem cell purification, multi-drug resistance to cancer chemotherapy, and cellular signaling. He has been continuously funded by NIH grants since 2000. He is a member of the American Society of Hematology (ASH), American Association for Cancer Research (AACR), and has been elected to the American Society for Clinical Investigations (ASCI). He served as a chartered member of the Developmental Therapeutics study section from 2005 to 2009 and currently serves as a charter member of the AIDS associated Opportunistic Infections and Cancer (AOIC) study section.Research interests in several areas of cancer, including AIDS-associated cancers, cancer drug resistance, biology of normal and leukemic hematopoietic stem cells, programmed cell death and cellular signaling.
Roy E. Smith, MD is a Professor of Medicine at the University of Pittsburgh School of Medicine, Department of Medicine, Division of Hematology-Oncology. He is board certified in hematology and medical oncology. After completing his post-doctoral training, Dr. Smith joined the faculty at the Ohio State University (OSU) where he served as the director of the Hematology Fellowship Training Program, the Clinical Coagulation Service, and the OSU Hemophilia Center. Dr. Smith is a former chairman of the Central Investigational Review Board for Cancer Therapy Evaluation Program of the National Cancer Institute and has played a key role in revising its
Roy E. Smith, MD is a Professor of Medicine at the University of Pittsburgh School of Medicine, Department of Medicine, Division of Hematology-Oncology. He is board certified in hematology and medical oncology. After completing his post-doctoral training, Dr. Smith joined the faculty at the Ohio State University (OSU) where he served as the director of the Hematology Fellowship Training Program, the Clinical Coagulation Service, and the OSU Hemophilia Center. Dr. Smith is a former chairman of the Central Investigational Review Board for Cancer Therapy Evaluation Program of the National Cancer Institute and has played a key role in revising its role in the conduct of Cooperative Group Pogram trials. His research interests includes Colorectal Cancer, Bleeding and Thrombostic Disorders.
Dr. Pudur Jagadeeswaran is a Professor in the Department of Biological Sciences at the University of North Texas. He received his graduate training at the Indian Institute of Science and his postdoctoral training at Yale University. He held faculty appointments both in Chicago at the University of Illinois College of Medicine and San Antonio at the University of Texas Health Science Center prior to coming to the University of North Texas. For over three decades his focus has been on the genetics of blood diseases with a special emphasis on blood clotting disorders. He introduced the zebrafish model to study
Dr. Pudur Jagadeeswaran is a Professor in the Department of Biological Sciences at the University of North Texas. He received his graduate training at the Indian Institute of Science and his postdoctoral training at Yale University. He held faculty appointments both in Chicago at the University of Illinois College of Medicine and San Antonio at the University of Texas Health Science Center prior to coming to the University of North Texas. For over three decades his focus has been on the genetics of blood diseases with a special emphasis on blood clotting disorders. He introduced the zebrafish model to study the genetics of hemostasis and thrombosis. His current interest is the identification of genes involved in hemostasis and thrombosis by genome-wide knockdowns.
Dr. Anver KULIEV received Doctorial degree from Institute of Human Morphology, Academy of Medical Sciences (AMS), USSR in 1970, M.D from Azerbaijan State Medical Institute, Baku, Azerbaijan in 1966. He has memberships in Editorial Board of Reproductive Biomedicine Online,Executive Director of Preimplantation Genetic Diagnosis (PGD) International Society (PGDIS), Director of WHO Collaborating Center for Prevention of Genetic Disorders, American Society of Hum Genetics; NY Acad. Sciences. He is Currently working as Clinical Professor, Florida International University, USA. He has published more than 150 research artiles in international journals abd written 13 books. Research interest includes Preimplantation Genetic Diagnosis
Dr. Anver KULIEV received Doctorial degree from Institute of Human Morphology, Academy of Medical Sciences (AMS), USSR in 1970, M.D from Azerbaijan State Medical Institute, Baku, Azerbaijan in 1966. He has memberships in Editorial Board of Reproductive Biomedicine Online,Executive Director of Preimplantation Genetic Diagnosis (PGD) International Society (PGDIS), Director of WHO Collaborating Center for Prevention of Genetic Disorders, American Society of Hum Genetics; NY Acad. Sciences. He is Currently working as Clinical Professor, Florida International University, USA. He has published more than 150 research artiles in international journals abd written 13 books. Research interest includes Preimplantation Genetic Diagnosis (PGD) for monogenic (including hemoglobinopathies) and chromosomal Disorders; Preimplantation HLA Typing; Embryonic Stem Cell Research.
Dr. Claudio Fozza is presently an Aggregate Professor, Blood Diseases, Department of Biomedical Sciences, University of Sasskari. He is also a Consultant in Haematology, Haematology Department, University of Sassari, since June 2007. Researcher in Blood Diseases, Institute of Haematology, University of Sassari, since December 2006. Academic teaching at the University of Sassari, chair of Haematology since 2006. Dr. Fozza is member in many scientific societies.His research focus on T-cell receptor repertoire, Regulatory T-cells, Myelodysplastic Syndromes.
Dr. Claudio Fozza is presently an Aggregate Professor, Blood Diseases, Department of Biomedical Sciences, University of Sasskari. He is also a Consultant in Haematology, Haematology Department, University of Sassari, since June 2007. Researcher in Blood Diseases, Institute of Haematology, University of Sassari, since December 2006. Academic teaching at the University of Sassari, chair of Haematology since 2006. Dr. Fozza is member in many scientific societies.His research focus on T-cell receptor repertoire, Regulatory T-cells, Myelodysplastic Syndromes.
Moshe Talpaz, M.D., Associate Chief, Division of Hematology/Oncology, is a leading clinical investigator in hematologic malignancies.Dr. Talpaz joined U-M in 2006, from M.D. Anderson Cancer Center in Houston, where he was professor of medicine and held the David Bruton Chair for Cancer Research. He has authored or co-authored nearly 400 articles in top national journals and textbooks, and is a member of the American Society of Hematology and the NCCN Chronic Myelogenous Leukemia Guidelines Panel. Dr. Talpaz focuses on the treatment of chronic myelogenous leukemia (CML) and brings special expertise in immunotherapy, cytokines and biologic response modifiers.
Moshe Talpaz, M.D., Associate Chief, Division of Hematology/Oncology, is a leading clinical investigator in hematologic malignancies.Dr. Talpaz joined U-M in 2006, from M.D. Anderson Cancer Center in Houston, where he was professor of medicine and held the David Bruton Chair for Cancer Research. He has authored or co-authored nearly 400 articles in top national journals and textbooks, and is a member of the American Society of Hematology and the NCCN Chronic Myelogenous Leukemia Guidelines Panel. Dr. Talpaz focuses on the treatment of chronic myelogenous leukemia (CML) and brings special expertise in immunotherapy, cytokines and biologic response modifiers.
Dr. Kamble is Associate Professor of Medicine in Hematology-Oncology, Cell and Gene Therapy, Baylor College of Medicine and The Methodist Hospital, Houston, TX. He completed his residency and fellowship training in Internal Medicine and Hematology-Oncology from University of Tennessee and University of Arkansas for Medical Sciences respectively. He was conferred Union against cancer (ICRETT, Geneva) award in 1994 to study molecular aspect of chronic myelogenous leukemia and bone marrow transplant in Hammersmith hospital, London and Central Science and Industrial Research (CSIR) award in 1995 to study stem cell transplantation in Cornell University, New York. Dr. Kamble is board certified in
Dr. Kamble is Associate Professor of Medicine in Hematology-Oncology, Cell and Gene Therapy, Baylor College of Medicine and The Methodist Hospital, Houston, TX. He completed his residency and fellowship training in Internal Medicine and Hematology-Oncology from University of Tennessee and University of Arkansas for Medical Sciences respectively. He was conferred Union against cancer (ICRETT, Geneva) award in 1994 to study molecular aspect of chronic myelogenous leukemia and bone marrow transplant in Hammersmith hospital, London and Central Science and Industrial Research (CSIR) award in 1995 to study stem cell transplantation in Cornell University, New York. Dr. Kamble is board certified in Internal Medicine and Medical Oncology. He has published extensively in prestigious journals including, Blood, Biology of Bone marrow transplantation and Journal of Clinical Oncology and regularly reviews manuscripts for Blood, Journal of clinical Oncology, American Journal of Hematology, Biology of bone marrow transplantation and Bone marrow transplant. Dr. Kamble is primarily interested in hematologic malignancies including multiple myeloma and hematopoietic stem cell transplantation.
Han-Mou Tsai, M.D., a consultant in hematology, was formerly Professor of Medicine and Associated Unified Head of the Division of Hematology at Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York; and Professor of Medicine and Pathology, M. Elaine Eyster M.D. Professor of Hematology and Chief of Hemostasis and Thrombosis Section at Pennsylvania State University College of Medicine and Hershey Medical Center, Hershey, Pennsylvania. Dr. Tsai's research interest focuses on the homeostasis of von Willebrand factor, ADAMTS13, thrombotic thrombocytopenic purpura, the hemolytic uremic syndrome and other disorders of thrombotic microangiopathy.
Han-Mou Tsai, M.D., a consultant in hematology, was formerly Professor of Medicine and Associated Unified Head of the Division of Hematology at Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York; and Professor of Medicine and Pathology, M. Elaine Eyster M.D. Professor of Hematology and Chief of Hemostasis and Thrombosis Section at Pennsylvania State University College of Medicine and Hershey Medical Center, Hershey, Pennsylvania. Dr. Tsai's research interest focuses on the homeostasis of von Willebrand factor, ADAMTS13, thrombotic thrombocytopenic purpura, the hemolytic uremic syndrome and other disorders of thrombotic microangiopathy.
Dr. Gustavo Rivero, M.D. is an Assistant Professor in the division of Medicine-Hematology and Oncology, Baylor College of Medicine. He completed his hematology and oncology training at the National Heart Lung Blood Institute in NIH. Dr. Gustavo Rivero, MD is board certified in Internal Medicine and Hematology. His area of expertise includes hematological and lymphoid malignancies. Dr. Rivero has special interest in drug development design for myelodysplastic syndrome and acute myelogenous leukemia. In addition, he actively participates in research intended to improve understanding of mechanisms of leukemogenesis and marrow failure associated with MDS.
Dr. Gustavo Rivero, M.D. is an Assistant Professor in the division of Medicine-Hematology and Oncology, Baylor College of Medicine. He completed his hematology and oncology training at the National Heart Lung Blood Institute in NIH. Dr. Gustavo Rivero, MD is board certified in Internal Medicine and Hematology. His area of expertise includes hematological and lymphoid malignancies. Dr. Rivero has special interest in drug development design for myelodysplastic syndrome and acute myelogenous leukemia. In addition, he actively participates in research intended to improve understanding of mechanisms of leukemogenesis and marrow failure associated with MDS.
Dr. Sasikanth Adigopula is an Advanced Heart Failure Cardiologist, Director of Heart Failure at Regional Medical Center and Assistant Professor in the Division of Cardiology at Loma Linda University. He completed his training at Stanford University and University of California at Los Angeles. He has authored many important papers and book chapters. He has published in prestigious medical journals including New England Journal of Medicine, Journal of the American College of Cardiology, Circulation, American Heart Journal, American Journal of Cardiology, Journal of American Society of Echocardiography and International Journal of Cardiovascular Imaging. He has received many national and international awards,
Dr. Sasikanth Adigopula is an Advanced Heart Failure Cardiologist, Director of Heart Failure at Regional Medical Center and Assistant Professor in the Division of Cardiology at Loma Linda University. He completed his training at Stanford University and University of California at Los Angeles. He has authored many important papers and book chapters. He has published in prestigious medical journals including New England Journal of Medicine, Journal of the American College of Cardiology, Circulation, American Heart Journal, American Journal of Cardiology, Journal of American Society of Echocardiography and International Journal of Cardiovascular Imaging. He has received many national and international awards, recognition and grants for his clinical and research work. Dr. Adigopula has presented his research in many national and international Cardiology conferences. He serves on the Editorial board of many peer-reviewed medical journals. He is dedicated to academics, teaching, patient care, research in advance heart failure and advancement in medicine. He is a member of American Heart Association, American College of Cardiology, International Society for Heart and Lung Transplantation, American Society of Echocardiography, Heart Failure Society of America, American Society of Nuclear Medicine and American Medical Association. He is a Fellow in the American College of Cardiology and the American College of Physicians. His research interest includes stem cell therapy in heart failure and clinical outcomes in advanced heart failure. His personal interests include piano, tennis and soccer but most importantly spending time with his young children. In his spare time, he volunteers in a free medical clinic and promotes charitable organizations such as UNICEF and Red Cross. Dr. Sasikanth Adigopula research interests includes stem cell therapy in Heart Failure, clinical outcomes in Advanced Heart Failure and Immunology in Heart Transplantation.
Dr. Omer Hassan Jamy is currently an Assistant Professor of Medicine in the Division of Hematology/Oncology at the University of Alabama at Birmingham, United States of America. He is also currently the principal investigator on several clinical trials focusing on AML, CML and allogeneic stem cell transplantation. Dr. Jamy completed his internal medicine residency from the University of Tennessee in Memphis followed by fellowship training in hematology/oncology and bone marrow transplantation and cellular therapy from the University of Alabama at Birmingham (UAB). His clinical and research interests include myeloid malignancies (acute myeloid leukemia, myelodysplastic syndrome, chronic myeloid leukemia and
Dr. Omer Hassan Jamy is currently an Assistant Professor of Medicine in the Division of Hematology/Oncology at the University of Alabama at Birmingham, United States of America. He is also currently the principal investigator on several clinical trials focusing on AML, CML and allogeneic stem cell transplantation. Dr. Jamy completed his internal medicine residency from the University of Tennessee in Memphis followed by fellowship training in hematology/oncology and bone marrow transplantation and cellular therapy from the University of Alabama at Birmingham (UAB). His clinical and research interests include myeloid malignancies (acute myeloid leukemia, myelodysplastic syndrome, chronic myeloid leukemia and myelofibrosis), acute lymphoblastic leukemia and allogeneic stem cell transplantation.
Dr. Yamada received her MD from Tokyo Women's Medical University. She completed residency training in Ophthalmology at Keio University, Tokyo. Following residency training, she completed a fellowship in Ophthalmology and accepted a position as an attending physician in Ophthalmology at Yokohama Municipal Citizen's Hospital in Yokohama, Japan, then joined the faculty of Nippon Kokan Hospital in Kawasaki, Japan as Chairperson, Department of Ophthalmology. To fulfill her academic interest, Dr. Yamada initiated residency training in Anatomic and Clinical Pathology at Montefiore Medical Center/Albert Einstein College of Medicine and completed a fellowship in Blood Bank and Transfusion Medicine at Johns Hopkins
Dr. Yamada received her MD from Tokyo Women's Medical University. She completed residency training in Ophthalmology at Keio University, Tokyo. Following residency training, she completed a fellowship in Ophthalmology and accepted a position as an attending physician in Ophthalmology at Yokohama Municipal Citizen's Hospital in Yokohama, Japan, then joined the faculty of Nippon Kokan Hospital in Kawasaki, Japan as Chairperson, Department of Ophthalmology. To fulfill her academic interest, Dr. Yamada initiated residency training in Anatomic and Clinical Pathology at Montefiore Medical Center/Albert Einstein College of Medicine and completed a fellowship in Blood Bank and Transfusion Medicine at Johns Hopkins Medical Institutions, joined the faculty as a Clinical Assistant. She accepted a position as Assistant Professor and Associate Medical Director, Blood Bank and Transfusion Medicine at the University of California, Irvine, and then at University of Michigan. She works in AABB and American Society for Apheresis (ASFA) as a member of subcommittees, and Michigan Association of Blood Banks (MABB). Her research interest includes apheresis, especially plasmapheresis support for organ transplantations and thrombotic microangiopahty including TTP and aHUS, and transfusion associated hyperkalemia in pediatric population.
Dr. Saulius Girnius is an Assistant Professor of Medicine in the department of Hematology/Oncology and Bone Marrow Transplant at the University of Cincinnati. Dr. Girnius graduated from the University of Cincinnati College of Medicine followed by residency and fellowship training in Boston, Massachusetts. He completed a fellowship in amyloidosis at the Amyloidosis Center at Boston University, in addition to subspecialty training in hematology/oncology. His training in multiple myeloma was completed under the tutelage of Dr. Nikhil Munshi at the Veterans Administration Hospital in Boston and Dana-Farber Cancer Institute. He also gained both autologous and allogeneic stem cell
Dr. Saulius Girnius is an Assistant Professor of Medicine in the department of Hematology/Oncology and Bone Marrow Transplant at the University of Cincinnati. Dr. Girnius graduated from the University of Cincinnati College of Medicine followed by residency and fellowship training in Boston, Massachusetts. He completed a fellowship in amyloidosis at the Amyloidosis Center at Boston University, in addition to subspecialty training in hematology/oncology. His training in multiple myeloma was completed under the tutelage of Dr. Nikhil Munshi at the Veterans Administration Hospital in Boston and Dana-Farber Cancer Institute. He also gained both autologous and allogeneic stem cell transplantation experience at Dana Farber. He has a special interest in plasma cell dyscrasia, including multiple myeloma, AL amyloidosis, and light chain deposition disease.
Dr. Phillips received her undergraduate B.A. and medical degree with honors from Brown University. She received her M.P.H. from Harvard University. She then received her internal medicine training at New York-Presbyterian/Columbia University Medical Center, where she also completed her fellowship in Hematology/Oncology. Adrienne A. Phillips, M.D., M.P.H. is an Assistant Professor of Medicine at Weill Cornell Medical College and Assistant Attending Physician at the New York-Presbyterian Hospital. Dr. Phillips is involved in clinical and translational research in HTLV-Related Adult T-Cell Leukemia Lymphoma (ATLL) and stem cell transplantation. She has developed the largest database of patients with ATLL in New York
Dr. Phillips received her undergraduate B.A. and medical degree with honors from Brown University. She received her M.P.H. from Harvard University. She then received her internal medicine training at New York-Presbyterian/Columbia University Medical Center, where she also completed her fellowship in Hematology/Oncology. Adrienne A. Phillips, M.D., M.P.H. is an Assistant Professor of Medicine at Weill Cornell Medical College and Assistant Attending Physician at the New York-Presbyterian Hospital. Dr. Phillips is involved in clinical and translational research in HTLV-Related Adult T-Cell Leukemia Lymphoma (ATLL) and stem cell transplantation. She has developed the largest database of patients with ATLL in New York and she is principal investigator of several clinical trials that explore novel therapies for this disease. Her research has been presented nationally and internationally. She has co-authored numerous publications in journals such as Cancer, Journal of Blood Medicine, and Leukemia and Lymphoma. She has also served as an oncology consultant in Africa, the Caribbean and Latin America.
Dr. Sahay is currently working as assistant professor in the division of Pulmonary Medicine at the reputed Baylor College of Medicine, Houston, Texas. He has immense clinical and research interest in Pulmonary Hypertension. He has published numerous research publications and his research work has been cited multiple times. While many know Dr. Sahay primarily through his work on pulmonary hypertension, his research papers are published in the prestigious journals. Considering his expertise in the field, Dr Sahay was selected as a member of the Pulmonary Vascular diseases steering committee by the American College of Chest Physicians. He is member
Dr. Sahay is currently working as assistant professor in the division of Pulmonary Medicine at the reputed Baylor College of Medicine, Houston, Texas. He has immense clinical and research interest in Pulmonary Hypertension. He has published numerous research publications and his research work has been cited multiple times. While many know Dr. Sahay primarily through his work on pulmonary hypertension, his research papers are published in the prestigious journals. Considering his expertise in the field, Dr Sahay was selected as a member of the Pulmonary Vascular diseases steering committee by the American College of Chest Physicians. He is member of prestigious societies like, American College of Chest Physicians, American Thoracic Society, European Respiratory Society and Pulmonary Hypertension Association.
Dr. Michael Keng holds a clinical faculty appointment as Assistant Professor in Medicine in the Division of Hematology/Oncology at the University of Virginia. He attended medical school at Michigan State University in East Lansing, Michigan and completed internal medicine residency at University of Southern California in Los Angeles, California. He completed fellowship in Hematology and Medical Oncology at the Cleveland Clinic, Cleveland, Ohio, where he served as chief fellow. Dr. Keng is a member of the American Society of Hematology (ASH) and American Society of Clinical Oncology (ASCO). His clinical areas of interest are: myelodysplastic syndromes, myeloproliferative disorders, acute myeloid
Dr. Michael Keng holds a clinical faculty appointment as Assistant Professor in Medicine in the Division of Hematology/Oncology at the University of Virginia. He attended medical school at Michigan State University in East Lansing, Michigan and completed internal medicine residency at University of Southern California in Los Angeles, California. He completed fellowship in Hematology and Medical Oncology at the Cleveland Clinic, Cleveland, Ohio, where he served as chief fellow. Dr. Keng is a member of the American Society of Hematology (ASH) and American Society of Clinical Oncology (ASCO). His clinical areas of interest are: myelodysplastic syndromes, myeloproliferative disorders, acute myeloid leukemia, chronic myeloid leukemia, acute lymphoid leukemia, aplastic anemia, and quality improvement.
Luca Arcaini is Assistant Professor of Hematology at University of Pavia School of Medicine, Pavia, Italy. He has authored and co-authored 126 papers on hematological malignancies. His research interest includes non-Hodgkin's lymphomas.
Dr. Serdar Sivgin is an Assistant Professor of Medicine in the Department of Hematology/Oncology and Bone Marrow Transplant at the University of Erciyes, Kayseri, Turkiye. Dr. Sivgin graduated from the University of Ege in 1999 and received his specialty of internal medicine in 2004 at Erciyes University, Turkiye. He completed his hematology fellowship in 2014 and degree of Associate Professor from Erciyes University. His training is mostly on leukemia, lymphomas and multipile myeloma with experience in the field of hematopoietixc stem cell transplantation. His private study field is iron overload and related complications in autologous and allogeneic HSCT recipients.
Dr. Serdar Sivgin is an Assistant Professor of Medicine in the Department of Hematology/Oncology and Bone Marrow Transplant at the University of Erciyes, Kayseri, Turkiye. Dr. Sivgin graduated from the University of Ege in 1999 and received his specialty of internal medicine in 2004 at Erciyes University, Turkiye. He completed his hematology fellowship in 2014 and degree of Associate Professor from Erciyes University. His training is mostly on leukemia, lymphomas and multipile myeloma with experience in the field of hematopoietixc stem cell transplantation. His private study field is iron overload and related complications in autologous and allogeneic HSCT recipients.
Ennio Avolio has completed his PhD from the University of Calabria, Comparative Neuroanatomy Lab., Arcavacata di Rende (CS), Italy and is currently doing his Post Doc in Neuroscience, University of California San Diego, Hypertension Lab., Medicine Dept. USA. He is the member of Societa Italiana di Neuropsicofarmacologia.
Ennio Avolio has completed his PhD from the University of Calabria, Comparative Neuroanatomy Lab., Arcavacata di Rende (CS), Italy and is currently doing his Post Doc in Neuroscience, University of California San Diego, Hypertension Lab., Medicine Dept. USA. He is the member of Societa Italiana di Neuropsicofarmacologia.
Dr. Gong graduated from the University of California, Los Angeles with a B.S. in biology. He obtained his medical degree from New York Medical College and receives his residency training in Internal Medicine at Cedars-Sinai Medical Center. His research interests in hematology and oncology include both hematologic and solid malignancies. His special interests include investigating the development of oncolytic reovirus as an anticancer agent in the treatment of both hematologic and solid cancers, particularly advanced sarcomas, and investigating the role of environmental risk factors in promoting the development of pancreatic adenocarcinoma.
Dr. Gong graduated from the University of California, Los Angeles with a B.S. in biology. He obtained his medical degree from New York Medical College and receives his residency training in Internal Medicine at Cedars-Sinai Medical Center. His research interests in hematology and oncology include both hematologic and solid malignancies. His special interests include investigating the development of oncolytic reovirus as an anticancer agent in the treatment of both hematologic and solid cancers, particularly advanced sarcomas, and investigating the role of environmental risk factors in promoting the development of pancreatic adenocarcinoma.
Dr. Suliburska has completed her Diploma of a Doctor of Pharmaceutical Sciences in Bromatology, Faculty of Pharmacy, the Poznan University of Medicine, 2001-2005, preparation of doctoral dissertation at the Department and Laboratory of Bromatology, Diploma of Master in Food Technology and Human Nutrition, Engineer, in the field of Human Nutrition, Faculty of Food Science and Nutrition, the Poznan University of Life Sciences, 1996-2001, Master's thesis prepared at the Department of Human Nutrition Hygiene. Currently she is working as Associate professor at the Department of Human Nutrition Hygiene, the Faculty of Food Science and Nutrition, the Poznan University of Life Sciences
Dr. Suliburska has completed her Diploma of a Doctor of Pharmaceutical Sciences in Bromatology, Faculty of Pharmacy, the Poznan University of Medicine, 2001-2005, preparation of doctoral dissertation at the Department and Laboratory of Bromatology, Diploma of Master in Food Technology and Human Nutrition, Engineer, in the field of Human Nutrition, Faculty of Food Science and Nutrition, the Poznan University of Life Sciences, 1996-2001, Master's thesis prepared at the Department of Human Nutrition Hygiene. Currently she is working as Associate professor at the Department of Human Nutrition Hygiene, the Faculty of Food Science and Nutrition, the Poznan University of Life Sciences in Poznan, since 2006.
All articles are fully peer reviewed, free to access and can be downloaded from our ClinMed archive.
Clinical Medical Image Library: 93.51
International Journal of Critical Care and Emergency Medicine: 92.83
International Journal of Sports and Exercise Medicine: 91.84
International Journal of Womens Health and Wellness: 91.79
Journal of Musculoskeletal Disorders and Treatment: 91.73
Journal of Geriatric Medicine and Gerontology: 91.55
Journal of Infectious Diseases and Epidemiology: 91.55
Clinical Medical Reviews and Case Reports: 91.40
International Archives of Nursing and Health Care: 90.87
International Journal of Ophthalmology and Clinical Research: 90.80
International Archives of Urology and Complications: 90.73
Journal of Clinical Nephrology and Renal Care: 90.33
Journal of Family Medicine and Disease Prevention: 89.99
Journal of Clinical Gastroenterology and Treatment: 89.54
Journal of Dermatology Research and Therapy: 89.34
International Journal of Clinical Cardiology: 89.24
International Journal of Radiology and Imaging Technology: 88.88
Obstetrics and Gynaecology Cases - Reviews: 88.42
International Journal of Blood Research and Disorders: 88.22
International Journal of Diabetes and Clinical Research: 87.97